Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Creative Medical Technology Holdings Inc
CELZCurrent price
2.81 USD
-0.34 USD (-10.79%)
Last closed
3.16 USD
ISIN
US22529Y3099
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
7 028 688 USD
Yield for 12 month
-33.41 %
1Y
3Y
5Y
10Y
15Y
CELZ
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Address: 211 East Osborn Road, Phoenix, AZ, United States, 85012
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30 USDP/E ratio
–Dividend Yield
–Current Year
+9 000 USD
Last Year
+88 600 USD
Current Quarter
+8 000 USD
Last Quarter
+3 000 USD
Current Year
-89 184 USD
Last Year
+60 109 USD
Current Quarter
-24 471 USD
Last Quarter
-29 271 USD
Key Figures CELZ
1 year
3 years
5 years
10 years
EBITDA
-5 956 393 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.27 %
PEG Ratio
–
Return On Equity TTM
-53.71 %
Wall Street Target Price
30 USD
Revenue TTM
17 000 USD
Book Value
5.69 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-83.9 %
Dividend Yield
–
Gross Profit TTM
39 805 USD
Earnings per share
-4.07 USD
Diluted Eps TTM
-4.07 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
358.9 %
Profit Margin
–
Dividend Analytics CELZ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CELZ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
12.06.2023
Dividend Date
03.02.2020
Stock Valuation CELZ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
56.0662
Price Sales TTM
413.4522
Enterprise Value EBITDA
-1.4548
Price Book MRQ
0.9232
Financials CELZ
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CELZ
For 52 weeks
2.65 USD
7.44 USD
50 Day MA
3.55 USD
Shares Short Prior Month
25 400
200 Day MA
4.12 USD
Short Ratio
1.06
Shares Short
29 587
Short Percent
2.27 %
BeatStart